Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Expert Panel Asks Ekam Pharma to Submit Global Prescribing Information Before Diazoxide 25 mg Clearance

Susmita Roy27 Dec 2025 8:37 PM IST

New Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO) has opined that Ekam Pharma...

Liv.72 Too Close to Liv.52: Calcutta HC Bars Shimla Drugs from Selling Product Imitating Himalaya

Susmita Roy26 Dec 2025 9:41 PM IST

New Delhi: The Calcutta High Court has passed an interim injunction in a trademark infringement and passing-off suit filed by Himalaya Global Holdings...

CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharma's Lenvatinib Capsules

Susmita Roy26 Dec 2025 9:00 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has accepted the Phase IV clinical trial...

Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans Appeal

Abbott's Vildagliptin SR Secures CDSCO Panel Nod on Post-Marketing Safety Data

Susmita Roy25 Dec 2025 7:32 PM IST

New Delhi: Abbott Healthcare has received a positive regulatory outcome after presenting the Active Post-Marketing Surveillance (PMS) study report for...

Natco Pharma Challenges Novo Nordisks Wegovy Patent, Reaches Delhi High Court

Fortis Arm Challenges Rs 7 Cr GST Demand: Delhi HC to Decide Tax on Inpatient Medicines

Susmita Roy24 Dec 2025 7:09 PM IST

The tax authorities alleged that the hospital collected GST on medicines and consumables billed at MRP to patients but failed to deposit the same with...

State Drug Alert: 141 Medicine Samples Including Mankind's Telmisartan Fail CDSCO Quality Tests in November

Susmita Roy23 Dec 2025 10:13 PM IST

New Delhi: Reflecting continuing concerns over medicine quality in India's pharmaceutical supply chain, the Central Drugs Standard Control...

Ayush Goes Global: India Introduces Ayush Mark, MAISP to Boost Quality and Credibility

Susmita Roy23 Dec 2025 10:08 PM IST

New Delhi: Marking a major step towards standardisation, safety and international acceptance of AYUSH systems, India has launched the Ayush Mark, a...

CDSCO Flags Popular Pantoprazole, Telmisartan Batches as Spurious in November Alert

Susmita Roy22 Dec 2025 4:01 PM IST

New Delhi: In a development that underscores growing concerns over counterfeit medicines in the supply chain, the Central Drugs Standard Control...

CDSCO Panel Declines to Consider ACME Generics' Phase IV Trial Results for Liothyronine Tablets

Susmita Roy22 Dec 2025 1:50 PM IST

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has declined to consider the...

Granting Study Leave is an Administrative Decision After ensuring Public Health Services Do not Get Affected: Calcutta High Court

Calcutta High Court Quashes Blacklisting of Helax Healthcare

Susmita Roy21 Dec 2025 5:30 PM IST

The action was taken in connection with the supply of Telmisartan Tablet IP 40 mg under a state government tender.

CDSCO Alert: 64 Drug Batches Including Metformin, Paracetamol Declared Not of Standard Quality in November

Susmita Roy20 Dec 2025 6:36 PM IST

New Delhi: In a strong reminder of persistent quality concerns in India's pharmaceutical supply chain, 64 batches of drugs and medical products have...

Zydus to commercialize Vascular Endothelial Growth Factor inhibitor Nufymco in US

Cipla Secures Exclusive Rights to Sell Corex, Dolonex, Neksium, Dalacin C Under Pfizer Deal

Susmita Roy20 Dec 2025 6:30 PM IST

New Delhi: Cipla Limited has entered into a five-year exclusive supply and marketing agreement with Pfizer Products India Private Limited and Pfizer...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok